Dr Reddy’s Lab Q3 results: PAT up 11%, beats estimates on strong US sales

Posted on by


Indian pharmaceutical firm Dr Reddy’s Laboratories beat estimates for third-quarter profit on Tuesday, helped by strong performance in its generic drugs business in key U.S. and European markets.


The Hyderabad-based company reported an 11% rise in consolidated net profit to 13.81 billion rupees ($166.17 million) for the quarter ended Dec. 31, compared with analysts’ estimates of 12.77 billion rupees, according to LSEG data.

First Published: Jan 30 2024 | 4:36 PM IST